{COPYRIGHT NASAL DELIVERY A NEW HOPE FOR MENTAL HEALTH CHALLENGES IN THE CONTINENT ?

The introduction of esketamine delivery system represents a potential shift in the treatment of treatment-resistant depressive illness across Europe . While traditionally requiring hospital-based administration, this formulation allows for a more degree of recipient autonomy , although specialist